Searchable abstracts of presentations at key conferences in endocrinology

ea0079016 | Abstracts | BES2021

Characteristics, pregnancy outcomes and tolerance of screening tests according to the preference of women for the method of GDM screening

Lore Raets , Marie Vandewinkel , Paul Van Crombrugge , Carolien Moyson , Johan Verhaeghe , Sofie Vandeginste , Hilde Verlaenen , Chris Vercammen , Toon Maes , Els Dufraimont , Block Christophe De , Yves Jacquemyn , Farah Mekahli , Katrien De Clippel , Den Bruel Annick Van , Anne Loccufier , Annouschka Laenen , Roland Devlieger , Chantal Mathieu , Katrien Benhalima

Aims: To compare the characteristics, pregnancy outcomes and tolerance of screening tests between women who prefer a two-step screening strategy with a glucose challenge test (GCT), women who prefer an one-step screening strategy with an oral glucose tolerance test (OGTT) and women without clear preference for screening method for gestational diabetes mellitus (GDM). Methods: 1803 women from a Belgian multi-centric prospective cohort study (BEDIP-N study...

ea0084ps3-13-115 | Pregnancy & Iodine | ETA2022

Higher thyroid FT3-to-FT4 ratio is associated with gestational diabetes mellitus and adverse pregnancy outcomes

Raets Lore , Minschart Caro , Van Den Bruel Annick , Van en Bogaert Emmelien , Van Crombrugge Paul , Moyson Carolien , Verhaeghe Johan , Vandeginste Sofie , Verlaenen Hilde , Vercammen Chris , Maes Toon , Dufraimont Els , Roggen Nele , De Block Christophe , Jacquemyn Yves , Mekahli Farah , De Clippel Katrien , Loccufier Anne , Laenen Annouschka , Devlieger Roland , Mathieu Chantal , Decallonne Brigitte , Benhalima Katrien

Aim: To determine the association between thyroid function and the risk for gestational diabetes mellitus (GDM) and adverse pregnancy outcomes.Methods: This case-control study was a sub-analysis of the BEDIP-N study, in which 199 GDM women were matched for age and body mass index with 398 controls. Thyroid stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3), and thyroid peroxidase (TPO) antibodies were measured at 6-14 weeks and ...